Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Safety and immunogenicity of an anti-Middle East respirat... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial
0
Authors
Kayvon Modjarrad
34 more
Kayvon Modjarrad
•
Christine Roberts
32 more
•
Joel Maslow
Published
July 24, 2019
Paper
Conversation
0
Reviews
0
Bounties
0
Abstract
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet Infectious Diseases
Topics
Medicine
Immunology
Internal Medicine
Infectious Diseases
Health
Show all topics
DOI
10.1016/s1473-3099(19)30266-x
License
publisher-specific-oa
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet Infectious Diseases
Topics
Medicine
Immunology
Internal Medicine
Infectious Diseases
Health
Show all topics
DOI
10.1016/s1473-3099(19)30266-x
License
publisher-specific-oa
